PHARMA
PHARMAPharmaceutical Hydrogenation Membrane in Taiwan
Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Taiwan's semiconductor manufacturing sector is a significant consumer of ultra-pure hydrogen, while the island's net-zero pathway includes green hydrogen for industrial decarbonization.
Market Context
TaiwanPolicy
H₂ Target
Cities
Industries
Ultra-Clean Hydrogen Source
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
GMP-Compatible On-Site Generation
On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.
Batch-Flexible Operation
Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.
Pharmaceutical Hydrogenation in Taiwan’s Hydrogen Market
Taiwan's semiconductor manufacturing sector is a significant consumer of ultra-pure hydrogen, while the island's net-zero pathway includes green hydrogen for industrial decarbonization. Offshore wind development around Kaohsiung creates opportunities for wind-to-hydrogen projects.
IONZERA supports Taiwan's dual hydrogen needs: ultra-pure H2 for semiconductor fabs via on-site electrolysis, and green hydrogen for industrial decarbonization.
Lower Resistance
Thinner Profile
PERFORMANCE ADVANTAGE
Why IONZERA for Pharmaceutical Hydrogenation in Taiwan
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
Shipping & Logistics
Air freight from India to Taipei in 4-5 business days.
Area Resistance
3x LOWERThickness
20% THINNERFrequently Asked Questions
Why choose IONZERA for pharmaceutical hydrogenation in Taiwan?
IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Taiwan. IONZERA supports Taiwan's dual hydrogen needs: ultra-pure H2 for semiconductor fabs via on-site electrolysis, and green hydrogen for industrial decarbonization.
Can IONZERA-based electrolysers produce semiconductor-grade hydrogen?
IONZERA membranes enable high-efficiency alkaline electrolysis with low gas crossover (<0.5% H2 in O2). When paired with appropriate purification stages, AWE systems using IONZERA can produce hydrogen suitable for semiconductor fabrication processes.
EXPLORE MORE
Request Pharmaceutical Hydrogenation Samples for Taiwan
Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Taiwan-based projects.
Request Sample